BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29791673)

  • 21. Confocal microscopy: imaging cervical precancerous lesions.
    Carlson K; Pavlova I; Collier T; Descour M; Follen M; Richards-Kortum R
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S84-8. PubMed ID: 16143376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASC, TBS, and the power of ALTS.
    Stoler MH
    Am J Clin Pathol; 2007 Apr; 127(4):489-91. PubMed ID: 17369124
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
    Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
    Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New guidelines: fewer PAP tests for women older than 30 years and less aggressive treatment for adolescents.
    Hill DA
    Am Fam Physician; 2009 Jul; 80(2):131. PubMed ID: 19621852
    [No Abstract]   [Full Text] [Related]  

  • 26. Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines.
    Duarte-García A; Cavalcante M; Arabelovic S; Wong JB
    ACR Open Rheumatol; 2019 May; 1(3):188-193. PubMed ID: 31777794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cervical cancer in developing countries.
    Cronjé HS
    Int J Gynaecol Obstet; 2004 Feb; 84(2):101-8. PubMed ID: 14871510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing Premalignant Lesions of Uterine Cervix in A ResourceConstraint Setting: A Narrative Review.
    Grema BA; Aliyu I; Michael GC; Mafala MB
    West Afr J Med; 2019; 36(1):48-53. PubMed ID: 30924116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should cervical cancer screening begin at age 21 for everyone? A quantitative analysis in a high-risk, low-income, African American/Hispanic young-adult population.
    Saeed-Vafa D; Huang Y; Manucha V
    Diagn Cytopathol; 2014 Mar; 42(3):205-12. PubMed ID: 23897742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2013 Dec; 122(6):1338-67. PubMed ID: 24264713
    [No Abstract]   [Full Text] [Related]  

  • 31. An Appraisal of Clinical Practice Guidelines for Diabetic Retinopathy.
    Wu CM; Wu AM; Young BK; Wu DJ; Margo CE; Greenberg PB
    Am J Med Qual; 2016 Jul; 31(4):370-5. PubMed ID: 25742906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Precancerous changes in the cervix uteri].
    Miljković S
    Med Pregl; 1978; 31(11-12):509-10. PubMed ID: 739960
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry.
    Shirata NK; Longatto Filho A; Roteli-Martins C; Espoladore LM; Pittoli JE; Syrjänen K
    Anal Quant Cytol Histol; 2003 Aug; 25(4):210-4. PubMed ID: 12961827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
    Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
    Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New guidelines in regard to cervical cancer screening].
    Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
    Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASCUS; borderline changes; epithelial abnormality; Pap class III -- what's in a name?
    Deery A
    Cytopathology; 2003 Oct; 14(5):231-4. PubMed ID: 14510885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytological findings of precancerous lesion and early cancer in the uterine cervix (author's transl)].
    Kurihara S
    Rinsho Byori; 1976; 24(6):446-51. PubMed ID: 988262
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of contact fluorescent colpomicroscopy in the diagnosis of pathological processes of the cervix uteri].
    Garmanova NV; Bokhman IaV; Drulia EM
    Akush Ginekol (Mosk); 1987 Jul; (7):37-41. PubMed ID: 3688328
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical-cancer screening--new guidelines and the balance between benefits and harms.
    Sawaya GF
    N Engl J Med; 2009 Dec; 361(26):2503-5. PubMed ID: 19940285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.